Trial intelligence / Profile preview

NEO6860 in Osteoarthritis of the Knee Pain

NCT02712957Phase 2Completed

Sponsor
Neomed Institute
Start
Mar 2016
Primary completion
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of NEO6860 in knee osteoarthritis (OA), sponsored by Neomed Institute. Started Mar 2016; status: completed.

02

Drugs

NEO6860
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT02712957.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02712957.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call